Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine
- PMID: 2417701
- PMCID: PMC11038321
- DOI: 10.1007/BF00199378
Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine
Abstract
The human prostate tumor subline 1-LN-PC-3-1A (1-LN) is reproducibly metastatic in adult athymic nude mice. Cells surviving a brief in vitro exposure to ethyl methanesulfonate (EMS) exhibited a profound decrease in capacity for experimental lung metastasis in nude mice. Thirty days after EMS treatment, 1 X 10(6) uncloned EMS-treated 1-LN cells (1-LN-EMS-10) were injected IV into groups of 6 to 8-week-old male athymic nude mice (BALB/cAnBOM). A median of 8.5 colonies/lung was observed among 20 1-LN-EMS-10-injected mice, which was significantly different from the median of 51 colonies/lung produced among 14 1-LN-injected mice (P = 0.0002). This altered phenotype remained stable during 150 days of continuous culture. However, the 1-LN-EMS-10 cells were tumorigenic in 10/10 nude mice injected SC. Single lung tumor colonies recovered from 1-LN-EMS-10-injected mice and reinjected IV into nude mice produced medians of 32-63 colonies/lung. The altered metastatic phenotype resulting from treatment of 1-LN with EMS was reversed by exposure to a noncytotoxic dose of 5-azacytidine, but unaffected by a second exposure to EMS. Collectively these data demonstrate that the metastatic phenotype of these human tumor cells in athymic nude mice can be heritably altered by in vitro exposure to EMS and 5-azacytidine. Analysis of the mechanisms underlying these phenotypic changes may provide insight into parts of the complex process of tumor cell evolution.
Similar articles
-
Clonal variation in the impact of ethyl methanesulfonate and 5-azacytidine on the metastatic phenotype of human prostatic tumor cells in athymic nude mice.Exp Cell Biol. 1988;56(5):270-6. doi: 10.1159/000163490. Exp Cell Biol. 1988. PMID: 2465929
-
Factors influencing phenotypic diversity of human prostate carcinoma cells metastasizing in athymic nude mice.Exp Cell Biol. 1985;53(3):163-9. doi: 10.1159/000163308. Exp Cell Biol. 1985. PMID: 4007233
-
Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.J Exp Med. 1984 May 1;159(5):1491-501. doi: 10.1084/jem.159.5.1491. J Exp Med. 1984. PMID: 6201588 Free PMC article.
-
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.J Cell Physiol Suppl. 1984;3:87-97. doi: 10.1002/jcp.1041210411. J Cell Physiol Suppl. 1984. PMID: 6205005 Review.
-
Metastases of human tumors in experimental animals.Anticancer Res. 1987 Sep-Oct;7(5B):997-1003. Anticancer Res. 1987. PMID: 3324940 Review.
Cited by
-
Clonal analysis of the malignant properties of B16 melanoma cells treated with the DNA hypomethylating agent 5-azacytidine.Clin Exp Metastasis. 1988 May-Jun;6(3):185-200. doi: 10.1007/BF01782479. Clin Exp Metastasis. 1988. PMID: 2450714
-
Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine.Clin Exp Metastasis. 1990 Nov-Dec;8(6):567-77. doi: 10.1007/BF00135878. Clin Exp Metastasis. 1990. PMID: 1699692
-
Chemical xenogenization of experimental tumors.Cancer Metastasis Rev. 1987;6(2):93-111. doi: 10.1007/BF00052845. Cancer Metastasis Rev. 1987. PMID: 3297373 Review.
-
Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer.Cancer Metastasis Rev. 1993 Sep;12(3-4):287-301. doi: 10.1007/BF00665959. Cancer Metastasis Rev. 1993. PMID: 8281614 Review.
-
Prostate cancer progression. Implications of histopathology.Am J Pathol. 1994 Nov;145(5):983-93. Am J Pathol. 1994. PMID: 7977655 Free PMC article. Review.
References
-
- Boon T. Antigenic tumor cell variants obtained with mutagens. Adv Cancer Res. 1983;39:121. - PubMed
-
- Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science. 1982;217:998. - PubMed
-
- Foulds L. Neoplastic Development. New York: Academic Press; 1975.
-
- Frost P, Kerbel RS. On a possible epigenetic mechanism(s) of tumor cell heterogeneity. Cancer Metastasis Rev. 1983;2:375. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical